A hormone report can show testosterone, estradiol or IGF-1 outside a reference range without telling you what to do next. The meaning depends on why the test was ordered, when the sample was taken, the laboratory method and the person’s health circumstances.
Testosterone, female reproductive hormones and growth hormone follow different interpretation rules. A single “hormone balance score” can misdirect assessment and treatment.
This guide focuses on interpreting results. For a broader discussion of treatment preparation and monitoring, see hormone testing before HRT or TRT.
What does a laboratory reference range tell you?
A reference range helps compare a result with the values expected for a defined population and laboratory method. It is not automatically a treatment target. Hormone interpretation also requires symptoms, sampling conditions and relevant medical history. A flagged value is a reason to investigate its meaning, rather than a prescription decision by itself.
Check the units: testosterone in ng/dL cannot be compared directly with nmol/L. Laboratory reference intervals also differ; an online target may be misleading.
The Endocrine Society’s July 2026 testosterone statement highlights inaccurate and non-standardised assays. A precise-looking number needs a sound measurement method and clinical interpretation.
Testosterone in men: why a low result needs context
Testosterone deficiency in men requires compatible symptoms and consistently low measured concentrations. One low value, especially without appropriate sampling conditions, is not enough. The Endocrine Society recommends confirming a suspected diagnosis with repeat morning fasting total testosterone measurement and investigating the cause when deficiency is established, rather than treating an isolated result.
The 2018 guideline also advises against routine general-population screening. Fatigue alone does not establish testosterone deficiency.
Bring the collection time and fasting details. Report recent illness, sleep, medications, testosterone and anabolic steroid use so the doctor can assess the sample and next step.
Total testosterone measures the overall amount in circulation. Much of it is attached to proteins. SHBG, or sex hormone-binding globulin, influences how much testosterone is available in the unbound form. MedlinePlus explains SHBG testing as an aid when the total result does not explain the clinical picture. An SHBG result also needs to be read alongside other information.
Free testosterone may help with borderline total values or altered SHBG, using an appropriate method. Commercial tests are not all equivalent.
What do LH and FSH add to a male testosterone assessment?
LH and FSH help a clinician investigate where a confirmed testosterone problem may originate. They are signals from the pituitary to the testes. Their pattern can help distinguish a testicular problem from one involving pituitary or hypothalamic signalling, but that pattern still needs medical interpretation and sometimes further investigation.
The guideline places this investigation after confirmed hypogonadism. Finding the cause can change the appropriate specialist assessment or treatment; LH and FSH do not complete a diagnosis from one low testosterone sample.
Discuss fertility before treatment: external testosterone can suppress sperm production. A higher testosterone number does not establish a better fertility outcome.
Female hormone results: cycle and life stage come first
Female hormone results must be read against menstrual history, life stage, symptoms and hormonal medication. Estradiol, progesterone, LH and FSH change across the cycle and answer different questions. A value that looks low in one phase may be expected in another, so a test without that context can create a misleading conclusion.
MedlinePlus describes progesterone’s cycle-related changes. A sample before the expected rise cannot be read as a post-ovulation sample. Collection timing depends on cycle length and the clinical question.
Estradiol is an estrogen; interpret it against the question, such as menstrual changes or ovarian function. MedlinePlus’s estrogen guide notes medicine and supplement effects. Report contraception and hormone therapy without stopping them independently.
Testosterone is present in women too. Testing may be relevant when androgen excess is suspected, but low desire is not diagnosed from a testosterone cut-off. The 2019 Global Consensus Position Statement on testosterone therapy for women finds no circulating androgen cut-off that separates women with and without sexual dysfunction. A symptom needs its own assessment.
Do menopause symptoms always need a hormone panel?
Typical menopause-related symptoms do not always require hormone testing to identify the life stage. NICE recommends a clinical diagnosis in otherwise healthy people aged 45 or over with the appropriate symptoms and history. Tests have a different role in younger or uncertain presentations and should be chosen to answer a specific clinical question.
The NICE menopause guideline places weight on menstrual changes and symptom patterns. It defines menopause clinically after at least 12 months without a period, when hormonal contraception is not being used. A clinician must account for circumstances such as hormonal treatment or hysterectomy.
FSH may help in selected younger presentations, but not to identify menopause during combined estrogen–progestogen contraception or high-dose progestogen use. Medication changes its interpretation.
Investigation of another illness is a separate question. Ask which decision each test would change; assessment does not require every reproductive hormone.
Growth hormone and IGF-1: why a random GH sample is limited
Growth hormone is released in pulses, so a random sample can catch a normal low point or a temporary peak. IGF-1 provides related information with less short-term variation, but it is not a standalone diagnosis. Suspected GH disorders need interpretation of the clinical picture and, in selected cases, dynamic testing under specialist care.
MedlinePlus explains random GH’s limited use: pulse timing changes results without indicating disease. A low value alone does not justify GH or a GH-releasing peptide.
IGF-1, or insulin-like growth factor 1, is influenced by GH. Its range changes with age, and results can be affected by other conditions. The MedlinePlus IGF-1 guide explains that a low result can reflect age-related change or another medical condition. It does not automatically establish deficiency.
The Endocrine Society adult GH deficiency guideline usually requires stimulation testing to confirm deficiency, with selected exceptions. A history of pituitary disease makes the investigation different from a general request to improve energy.
The Society’s Hormones and Aging statement addresses the distinction between endocrine disease and normal ageing. Treatment for established disease should not be extrapolated into a general anti-ageing indication.
Which question does each result help answer?
Each hormone test should be linked to a clinical question before its result is interpreted. Testosterone, reproductive hormones and GH-related tests are not interchangeable screening tools. This table describes their roles at a broad level; the clinician must decide which tests are appropriate and whether the findings warrant repeat measurement or further investigation.
| Result | Question it may help investigate | What it cannot decide alone |
|---|---|---|
| Total testosterone in men | Is testosterone repeatedly low in a person with compatible symptoms? | Whether to begin TRT from one sample |
| SHBG / appropriate free testosterone assessment | Does protein binding affect the total testosterone interpretation? | The cause of every fatigue or libido complaint |
| LH and FSH | Where might a confirmed sex-hormone problem originate? | A treatment plan without the rest of the assessment |
| Estradiol / progesterone | What does the result mean for this cycle, life stage and clinical question? | Whether every woman needs hormone replacement |
| IGF-1 | Is further investigation of a GH disorder warranted in this context? | A general need for GH supplementation |
| Dynamic GH testing | How does GH respond under a defined specialist test? | Whether GH is useful for general wellness |
What should you bring to a hormone-result consultation?
Bring the full report, including units, reference intervals and sample time, together with symptoms, medications and relevant cycle or fertility history. These details let the clinician evaluate whether the result answers the original question. The next step may be a repeat test, another investigation, a treatment discussion or reassurance that no hormone intervention is indicated.
Record symptom onset, affected activities and the last menstrual period where relevant. Note whether testing preceded or followed hormone treatment. Bring the full report rather than a cropped number.
ARPAR’s hormone consultation provides a place to review that information with a physician. If the symptoms need broader investigation, the health check-up information explains another route into assessment. Ask what diagnosis the doctor is considering and which finding would change the next decision.